Moderna🇺🇸
莫德纳
Listed (MRNA)
mRNA TherapeuticsCambridge, USEst. 20105,000+ employees
AMORA Score
Total
90
out of 100
\u{1F52C}
Advancement
9.2
\u{1F9E0}
Mastery
9.0
\u2699\uFE0F
Operations
8.8
\u{1F30D}
Reach
9.4
\u267B\uFE0F
Affinity
8.6
About
Moderna is a biotechnology company pioneering mRNA technology to create a new generation of transformative medicines. Their platform enables rapid development of vaccines and therapeutics across infectious diseases, oncology, and rare diseases.
公}司简介
Moderna是一家生物技术公司，开创了mRNA技术以创造新一代变革性药物。其平台能够快速开发针对传染病、肿瘤学和罕见疾病的疫苗和疗法。
🔒
Premium Intelligence
Unlock detailed funding data, team insights, technology analysis, supply chain mapping, and customer breakdown for this company.
Upgrade to PRO$19.9/moFunding & Valuation
Stage
Public (NASDAQ)
Total Funding
$12.8B
Valuation
$28.5B
Team & Leadership
CEO
Stéphane Bancel
Founders
Derrick Rossi, Noubar Afeyan, Robert Langer
Products & Technology
Core Products
Spikevax (mRNA-1273), mRNA-4157/V940, Pipeline of 40+ programs
Technology Route
mRNA platform, Lipid nanoparticle delivery
Patents
2,340
Supply Chain Tier
Platform
Use Cases
VaccinesOncology ImmunotherapyRare Diseases
Key Partners
MerckBARDANIH